Kristen Ambrose, SVP & Chief Accounting Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 2,793 shares at $489.46 ($1.4M) on 2026-02-17, disclosed to the SEC on 2026-02-19.
Seasonal sale ($1.4M) by SVP & Chief Accounting Officer — this insider has traded VRTX in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $483.75 | 598 | $289K | 21.4% |
| 2 | $489.46 | 1,557 | $762K | 56.3% |
| 3 | $473.68 | 638 | $302K | 22.3% |
| Total | $484.63 avg | 2,793 | $1.4M | 100% |
| Filing → |
| VRTX | SELL | 2026-02-12 | $634K | — | Filing → |
| VRTX | SELL | 2025-02-26 | $850K | — | Filing → |
| VRTX | SELL | 2025-02-19 | $611K | — | Filing → |